Trial Profile
Clinical trial, phase II. Evaluation of the antitumoral effect of monoclonal antibody h-R3 combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.